Loading clinical trials...
Loading clinical trials...
Randomized Controlled Cross-Over Pilot Study of the Effectiveness of the Vector NIV Device in Hypercapnic COPD Patients With Expiratory Flow Limitation
Conditions
Interventions
Modified BiPAP A40 with Vector Algorithm (Vector)
Modified BiPAP A40 with Standard of Care Settings
Locations
1
United States
Temple University Hospital
Philadelphia, Pennsylvania, United States
Start Date
January 21, 2020
Primary Completion Date
November 17, 2023
Completion Date
November 17, 2023
Last Updated
May 9, 2025
NCT05746039
NCT07190209
NCT07307781
NCT07073950
NCT07509606
NCT07451977
Lead Sponsor
Philips Clinical & Medical Affairs Global
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions